PATIENT-REPORTED AND QUALITY OF LIFE OUTCOMES FROM MYCARING, A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL OF ROZANOLIXIZUMAB IN GENERALISED MYASTHENIA GRAVIS

被引:0
|
作者
Habib, Ali A. [1 ]
Druzdz, Artur [2 ]
Grosskreutz, Julian [3 ]
Kaminski, Henry [4 ]
Mantegazza, Renato [5 ]
Sacconi, Sabrina [6 ]
Utsugisawa, Kimiaki [7 ]
Vissing, John [8 ]
Vu, Tuan [9 ]
Morel, Thomas [10 ]
Boehnlein, Marion [11 ]
Woltering, Franz [11 ]
Bozorg, Ali [12 ]
Gayfieva, Maryam [13 ]
Bril, Vera [14 ]
机构
[1] Univ Calif Irvine, Orange, CA 92668 USA
[2] Municipal Hosp Poznan, Poznan, Poland
[3] Univ Lubeck, Lubeck, Germany
[4] George Washington Univ, Med Ctr, Washington, DC 20037 USA
[5] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[6] CHU Nice, Nice, France
[7] Hanamaki Gen Hosp, Hanamaki, Japan
[8] Univ Copenhagen, Rigshosp, Copenhagen, Denmark
[9] Univ S Florida, Morsani Coll Med, Tampa, FL 33620 USA
[10] UCB Pharma, Brussels, Belgium
[11] UCB Pharma, Monheim, Germany
[12] UCB Pharma, Morrisville, NC USA
[13] UCB Pharma, Slough, Berks, England
[14] Univ Hlth Network, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S19 / S20
页数:2
相关论文
共 50 条
  • [21] Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: A double-blind, randomized, placebo-controlled study
    Fagien, Steven
    Cox, Sue Ellen
    Finn, J. Charles
    Werschler, W. Philip
    Kowalski, Jonathan W.
    DERMATOLOGIC SURGERY, 2007, 33 : S2 - S9
  • [22] A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF CYCLOSPORINE-A IN THE TREATMENT OF MYASTHENIA-GRAVIS
    TINDALL, RSA
    ROLLINS, JA
    PHILLIPS, JT
    GREENLEE, RG
    BELENDIUK, G
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 505 : 854 - 856
  • [23] Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study
    Antozzi, Carlo
    Vu, Tuan
    Ramchandren, Sindhu
    Nowak, Richard J.
    Farmakidis, Constantine
    Bril, Vera
    De Bleecker, Jan
    Yang, Huan
    Minks, Eduard
    Park, Jin-Sung
    Grudniak, Mariusz
    Smilowski, Marek
    Sevilla, Teresa
    Hoffmann, Sarah
    Sivakumar, Kumaraswamy
    Suzuki, Yasushi
    Youssef, Eriene
    Sanga, Panna
    Karcher, Keith
    Zhu, Yaowei
    Sheehan, John J.
    Sun, Hong
    LANCET NEUROLOGY, 2025, 24 (02): : 105 - 116
  • [24] Single fiber EMG as an outcome measure in myasthenia gravis: Results from a double-blind, placebo-controlled trial
    Meriggioli, MN
    Rowin, J
    JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 2003, 20 (05) : 382 - 385
  • [25] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [26] Mycophenolate mofetil for myasthenia gravis - A double-blind, placebo-controlled pilot study
    Meriggioli, MN
    Rowin, J
    Richman, JG
    Leurgans, S
    MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOMCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 : 494 - 499
  • [27] Dietary supplementation and quality of life of older patients: A randomized, double-blind, placebo-controlled trial
    Gariballa, Salah
    Forster, Sarah
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (12) : 2030 - 2034
  • [28] QUALITY OF LIFE OUTCOMES IN RAISE: A DOUBLE-BLIND RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ZILUCOPLAN IN GMG
    Weiss, Michael D.
    Genge, Angela
    Hussain, Yessar
    Kaminski, Henry J.
    Leite, M. Isabel
    Mantegazza, Renato
    Utsugisawa, Kimiaki
    Vu, Tuan
    Brock, Melissa
    Boroojerdi, Babak
    Vanderkelen, Mark
    de la Borderie, Guillemette
    Duda, Petra W.
    Howard, James F., Jr.
    MUSCLE & NERVE, 2022, 66 : S137 - S137
  • [29] ECULIZUMAB SAFETY AND EFFICACY IN REFRACTORY MYASTHENIA GRAVIS: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY
    Howard, J.
    Utsugisawa, K.
    Beneatr, M.
    Murai, H.
    Barohn, R.
    Sendra, I. I.
    Pons, C. C.
    Jacob, S.
    Cutter, Gary
    Vissing, J.
    Burns, T.
    Bleecker, J. D.
    Kissel, J.
    Muppidi, S.
    Nowak, R.
    O'Brien, F.
    Wang, J.
    Vu, T.
    Mantegazza, R.
    MUSCLE & NERVE, 2016, 54 (03) : 645 - 645
  • [30] A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis
    Strijbos, Ellen
    Tannemaat, Martijn R.
    Alleman, Iris
    de Meel, Robert H. P.
    Bakker, Jaap A.
    van Beek, Ruud
    Kroon, Frank P.
    Rimmelzwaan, Guus F.
    Verschuuren, Jan J. G. M.
    VACCINE, 2019, 37 (07) : 919 - 925